You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
Repository navigation
Separate Yarrowia lipid fraction from titer and hydrolysis from exclusive niches #1964
The full preprint identifies YBGL3/YBXT-XR, shared glucose use, inoculum-dependent lipid output and comparable best-consortium/monoculture titer. Repair the existing graph without claiming polymer depolymerization, uniform performance improvement, simultaneous glucose/xylose consumption or demonstrated burden relief. Retain the higher lipid fraction and temporal succession; qualify mediation. Do not restore #819 cross-feeder roles.
Six whole records and all 15 existing nodes/eight arrows inspected. Primary abstracts and relevant full-text sections checked; TCP and urease repairs are abstract-bounded. All-state issue search covered 1196 issues and hidden/ignored local paths; nine prior matching issue bodies read. This is not an audit of every historical PR comment.
Resolution
Address the existing graph in batch124; close only after protected-main merge. Source-based self-adversarial review is not independent approval.
Graph repair addressed; close only after protected-main merge. #1972 at f16d4d8; self-review #1972 (review). 1187 passed in 353.41s (0:05:53); postcommit docs-current passed. Six append-only histories, 61 validation outputs and twelve mutation probes recorded. No new topology or Edison provider submission in this batch; one dryrun only; prior research extensions remain incomplete. Self-review is not independent approval.
Activity
realmarcin commentedon Oct 8, 2026
Graph repair addressed; close only after protected-main merge. #1972 at f16d4d8; self-review #1972 (review). 1187 passed in 353.41s (0:05:53); postcommit docs-current passed. Six append-only histories, 61 validation outputs and twelve mutation probes recorded. No new topology or Edison provider submission in this batch; one dryrun only; prior research extensions remain incomplete. Self-review is not independent approval.